Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Brain Neoplasms 9Sarcoma 7Glioma 6Meningioma 5Lung Neoplasms 5Esophageal Neoplasms 5Pancreatic Neoplasms 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Rhabdomyosarcoma 3Radiation Injuries 3Glioblastoma 3Chondrosarcoma 3Uterine Cervical Neoplasms 2Solid Tumor 2Pituitary Neoplasms 2Pinealoma 2Osteosarcoma 2Oligodendroglioma 2Nerve Sheath Neoplasms 2Nasopharyngeal Carcinoma 2Liver Neoplasms 2Hodgkin Disease 2Head and Neck Neoplasms 2Ependymoma 2Craniopharyngioma 2Chordoma 2Cholangiocarcinoma 2

Interventions

pazopanib 2Ifosfamide 2Doxorubicin 2selinexor 1Trabectedin 1Sunitinib 1Proton Therapy 1Nivolumab 1Methotrexate 1Magnetic Resonance Spectroscopy 1Fluorodeoxyglucose F18 1FAPI-46 1Epirubicin 1Dasatinib 1Dacarbazine 1Cisplatin 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Solitary Fibrous Tumors × Proton Therapy × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡